This inventor holds 1 USPTO granted patent. Top assignee: Council of Scientific and Industrial Research. Active years: 2006.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2006
Title: Vummenthala Anuradha: Innovator in Pharmaceutical Composition
Introduction: Vummenthala Anuradha is a notable inventor based in Hyderabad, Telangana, India. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative treatments for various diseases.
Latest Patents: Anuradha holds a patent for his invention titled "α-Glucosidase inhibitors from a natural source." This invention relates to a method for providing α-glucosidase inhibition to a subject by administering a pharmaceutical composition that includes an α-glucosidase inhibitory agent. The agents selected for this composition include pipataline, sesamin, pellitorine, guineensine, and brachystamide-B. This invention has therapeutic applications for diabetes mellitus, cancer, and viral diseases such as hepatitis B and C, HIV, and AIDS. Additionally, the invention provides a process for the isolation of these α-glucosidase inhibitory agents from plant sources in significant yields.
Career Highlights: Vummenthala Anuradha is associated with the Council of Scientific & Industrial Research, where he has been involved in groundbreaking research and development. His work has contributed to advancements in the pharmaceutical industry, particularly in the area of natural compounds with therapeutic potential.
Collaborations: Anuradha has collaborated with esteemed colleagues such as Janaswamy Madhusudana Rao and Pullela Venkata Srinivas. These collaborations have further enhanced the impact of his research and innovations.
Conclusion: Vummenthala Anuradha is a distinguished inventor whose work in pharmaceutical compositions has the potential to significantly improve treatment options for various diseases. His contributions to the field exemplify the importance of innovation in healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
